- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID MK 3475-158_KEYNOTE-158
Trial Description
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724
Investigator
- John Wallmark, M.D.
Disease Types
Sponsor
- Merck Sharp & Dohme LLC
ClinicalTrials.gov NCT ID
- NCT02628067